Project Grant R35GM164210
- Federal Grant Award Summary The University of California, San Diego received a $638,334 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on September 8, 2025, with completion targeted for August 31, 2027. The award supports development of innovative computational methods and open-source software tools designed to advance drug design through thermodynamic mapping of proteins, ligands,...
- Federal Project Grant Award Summary The University of California, San Francisco received a $501,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 5, 2025, with completion targeted for May 31, 2030. The grant funds fundamental research focused on bridging the gap between predicted and actual protein structures in structural biology, with particular emphasis on understanding...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $124,767 to The Regents of the University of California, San Francisco under the Biomedical Research and Research Training program (CFDA 93.859) for the period May 1, 2026 through April 30, 2028. The award supports de novo protein design research focused on engineering proteins that bind small molecules and catalyze chemical reactions. The research builds on the investigator's...
- Federal Grant Award Summary The National Institute of General Medical Sciences awarded UC Riverside a $396,886 Project Grant on March 15, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop enabling technology for characterizing human proteoforms—the active molecular species in cells that include not only genetically encoded protein sequences but also post-translational modifications, alternative splice variants, and other chemical alterations. The research...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $150,104 to The Regents of the University of California, San Francisco under the Biomedical Research and Research Training program (CFDA 93.859) on August 8, 2026, with a completion date of February 29, 2028. The project, titled "De Novo Design of Allosterically Regulated Proteins to Study Intramolecular Signal Transduction," focuses on the rational design of novel proteins engineered...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Regents of the University of California, doing business as University of California, Berkeley, a Project Grant totaling $361,952 under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, with a completion date of June 30, 2030. This award funds fundamental research aimed at mapping and predicting the sequence-function landscape of biomedically...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $401,250 to The Regents of the University of California, doing business as University of California, Berkeley, under the Biomedical Research and Research Training program (CFDA 93.859) to develop an integrated computational framework for predicting drug molecular crystal solubility. The five-year project, which commenced on September 15, 2025 and concludes on July 31, 2030, delivers machine...
- Federal Grant Award Summary The University of California, Santa Barbara received a $391,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026, through April 30, 2031. The award supports the development of computational methodologies and tools to study liquid-liquid phase separation (LLPS) of intrinsically disordered proteins (IDPs), which form biomolecular condensates...
- Federal Project Grant Award Summary The University of California, Davis received a $341,970 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on March 15, 2026, with a completion date of February 28, 2030. The award supports the development of polarizable Gaussian multipole force fields for biomolecular simulations based on in-solution electrostatics. The research deliverables include...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded University of California, Berkeley a $226,560 Project Grant effective March 1, 2026, through December 30, 2028, under the Biomedical Research and Research Training program (CFDA 93.859). This award supports the development of new catalytic methods for modular synthesis of saturated, nitrogen-containing heterocycles guided by mechanism-aware machine learning models. The research addresses a...
The National Institute of General Medical Sciences (NIGMS) awarded a $399,391 Project Grant to the Regents of the University of California at Riverside on May 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859). The project, titled "Molecular Modeling and Theoretical Characterization of Protein Dynamics and Ligand Binding," focuses on developing and applying advanced molecular dynamics (MD) simulation techniques to enhance understanding of protein-ligand interactions at the atomic level. The research addresses critical gaps in computational modeling of binding affinity, binding kinetics (association and dissociation rates), and the effects of protein conformational changes on drug efficacy—particularly in complex cellular environments where proteins interact with multiple binding partners. The project deliverables include the continued development of modeling tools and methodologies to predict drug binding properties and facilitate rational drug design, with specific emphasis on understanding protein dynamics in protein complexes and designing small-molecule "molecular glues" for targeted protein degradation or functional inhibition. The research will be conducted at UC Riverside through February 28, 2031, and is anticipated to bridge knowledge gaps between in vitro binding studies and in vivo drug efficacy, ultimately supporting more effective therapeutic development across pharmaceutical and biomedical applications.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $399.4k | 4/23/26 |